Completed

NCT Number: NCT06464523

HPV Education, Early Diagnosis and Knowledge

The aim of this study was to determine the effect of health education given to female teachers on HPV knowledge and screening test. The population of the study consisted of all female teachers belonging to the Bucak Directorate of National Education between September 2021 and March 2022. The sample of the study consisted of 144 healthy female teachers who were registered in the institutions affiliated to the District Directorate of National Education between the specified dates, met the inclusion criteria and volunteered to participate in the study. In this study area, with the assumption that the rate of cervical cancer screening test of 70% of the women in the Healthy Life Centre after the trainings would be considered significant, the effect size d=0.18 was calculated to include at least 98 women in 3 groups at 95% power and 0.05 error level. The calculation was performed with the 'G Power 3.1.9.2' package programme. In this context, the total sample of the study was determined as 156 participants, 52 in each group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Female Teachers

Age range

18 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Burdur Mehmet Akif Ersoy University

Burdur, Bucak, 15000, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

to volunteer to participate in the study,
To be between the ages of 30-65,
being a woman teacher,
being married
to be able to make video calls.

Exclusion criteria

being pregnant or in the postnatal period,
a history of cervical cancer,
to have hysterectomy operation.

Treatment and study plan

Face to face education

Behavioral

In addition to the standard cervical cancer screening programme service, participants in this group received individual face-to-face health education on HPV and cervical cancer prevention through home visits and were given educational brochures. Participants in this group were interviewed a total of four times (four times face-to-face) during the research period.

Online education

Behavioral

In addition to the standard cervical cancer screening programme service, participants in this group received individual health education on HPV and cervical cancer prevention online via video call via WhatsApp application and were given a digital education brochure. Participants in this group were interviewed a total of four times (four times remotely) during the research process.

Primary outcomes

Human Papilloma Virus (HPV) Knowledge Scale:

Time frame: 5-10 minutes

HPV Knowledge Scale is a knowledge test developed by Waller et al. (2013) to determine the level of knowledge of individuals about HPV agent, HPV screening tests and vaccine. The scale, whose Turkish validity and reliability was conducted by Demir and Özdemir in 2019, has a total of 33 items. The HPV Knowledge Scale consists of four sub-dimensions: general HPV knowledge (items 1-16), HPV screening test knowledge (items 17-22), general HPV vaccine knowledge (items 23-27) and knowledge of the current HPV vaccination programme (items 28-33).

Sponsors and collaborators

Lead sponsor

Mehmet Akif Ersoy University

Other

Registry information

Official study title

The Effect of HPV Training on Early Diagnosis Screening and Knowledge Levels of Female Teachers

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Jun 18, 2024
Registry last updated: Jun 18, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.